HELIOS PHARMA AT THE SCIENTIFIC SYMPOSIUM "NUCLEAR MEDICINE FOR DIAGNOSIS AND TREATMENT IN THE ERA OF PRECISION MEDICINE
Helios Pharma was honored to join as a co-organizer of the scientific symposium “Nuclear Medicine for Diagnosis and Treatment in the Era of Precision Medicine,” successfully held on May 9, 2026 at Phenikaa University Hospital.
The symposium gathered nearly 300 healthcare professionals, scientists, and experts from leading hospitals, universities, and research institutions across Vietnam and internationally, creating a valuable platform for academic exchange and professional connection.
The program highlighted the latest advances in modern nuclear medicine, including PET/CT with novel radiopharmaceuticals, Lu-177 PSMA therapy for prostate cancer, pain palliation for bone metastases with ¹⁵³Sm, and ⁹⁰Y-Resin microspheres for liver cancer treatment.
We sincerely appreciate the opportunity to accompany this meaningful scientific event and remain committed to supporting medical advancement, professional collaboration, and better treatment opportunities for patients in Vietnam.
Read more:
Article on Suc Khoe & Doi Song
Post on Phenikaa University Hospital Fanpage
